Index of artpub/2022/270517/

Spicka, Ivan
Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high-risk cytogenetics : IKEMA subgroup analysis
2022
https://ddd.uab.cat/record/270517